Back to
Westfield Capital Management Co. LP
FATE
Showing 0 of 18 quarters
Position history for
Westfield Capital Management Co. LP's holdings in Fate Therapeutics, Inc.
No. Westfield Capital Management exited its FATE (Fate Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 1,386,058 shares worth $14M. Westfield Capital Management already held FATE in its Q4 2018 13F, the earliest on record, and held it in 17 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.